CAS: 870070-55-6 - 4-hydroxy-N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methylpiperidine-1-carboxamide
Formula:C19H26N4O4S
- Synonyms:
- Tozadenant
- 4-Hydroxy-4-Methyl-Piperidine-1-Carboxylic Acid(4-Methoxy-7-Morpholin-4-Yl-Benzothiazol-2-Yl)-Amide
- Syn-115
- 4-Hydroxy-N-(4-Methoxy-7-(4-Morpholinyl)-2-Benzothiazolyl)-4-Methyl-1-Piperidinecarboxamide
- Tozadenant (USAN)
- 4-Hydroxy-N-(4-methoxy-7-morpholinobenzo(d)thiazol-2-yl)-4-methylpiperidine-1-carboxamide
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Tozadenant REF: AN-AG004GR6CAS: 870070-55-6 | - - - | To inquire | Tue 21 May 24 |
 | Tozadenant REF: TM-T7320CAS: 870070-55-6 | 98% | 45.00 €~1,374.00 € | Tue 28 May 24 |
 | 4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide REF: 3D-VJB07055CAS: 870070-55-6 | Min. 95% | To inquire | Mon 01 Jul 24 |
Tozadenant
CAS:870070-55-6
Tozadenant (SYN115) is an adenosine A2A receptor antagonist(Ki of 11.5 nM and 6 nM on …
Formula:
C19H26N4O4S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
406.5
Ref: TM-T7320
| 1mg | 45.00 € | |
| 2mg | 58.00 € | |
| 5mg | 96.00 € | |
| 10mg | 142.00 € | |
| 25mg | 257.00 € | |
| 50mg | 447.00 € | |
| 100mg | 644.00 € | |
| 500mg | 1,374.00 € | |
| 1ml*10 (DMSO) | 94.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
![4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide](https://static.cymitquimica.com/products/3D/thumb/VJB07055.jpg)
4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide
CAS:870070-55-6
4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide is a novel, potent, and selective adenosine receptor antagonist. It has been shown to …
Formula:
C19H26N4O4S
Purity:
Min. 95%
Molecular weight:
406.5 g/mol
Ref: 3D-VJB07055
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
